Translating Immuno-oncology Biomarkers to Diagnostic Tests: A Regulatory Perspective

Pages: 701 - 716
Published: Sep 10, 2019
Abstract
The rapid development of effective immunotherapy using immune-checkpoint inhibitors (ICIs) against many different cancer types opened a new front in cancer treatment. Immunotherapy is undoubtedly one of the biggest breakthroughs in cancer therapy within the past decade. The identification of predictive biomarkers to select the patients most likely to respond to ICI monotherapies or emerging combination therapies remains one of the major unmet...
Paper Details
Title
Translating Immuno-oncology Biomarkers to Diagnostic Tests: A Regulatory Perspective
Published Date
Sep 10, 2019
Pages
701 - 716
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.